Biomarkers of diabetic nephropathy: A 2017 update

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Critical reviews in clinical laboratory sciences

• Publication date

  2017-07-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10408363.2017.1377682PMID 28956668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy

  2017cited by this paper
• Diabetic nephropathy: A potential savior with ‘rotten-egg’ smell

  2017cited by this paper
• Standards of Medical Care in Diabetes-2017: Summary of Revisions.

  2017cited by this paper
• NGAL as an Early Predictive Marker of Diabetic Nephropathy in Children and Young Adults with Type 1 Diabetes Mellitus

  2017cited by this paper
• Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy

  2017cited by this paper
• Waste, Leaks, and Failures in the Biomarker Pipeline.

  2017cited by this paper
• ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.

  2017cited by this paper
• Apolipoprotein C‐I plays a role in the pathogenesis of glomerulosclerosis

  2017cited by this paper
• Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis

  2017cited by this paper
• Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus

  2017cited by this paper
• Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study—Impact for mortality

  2017cited by this paper
• The association between interleukin-19 concentration and diabetic nephropathy

  2017influential reference
• Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.

  2017cited by this paper
• Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy

  2016cited by this paper
• Serum and Urinary Orosomucoid in Young Patients With Type 1 Diabetes

  2016cited by this paper
• Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling

  2016cited by this paper
• p66Shc: A novel biomarker of tubular oxidative injury in patients with diabetic nephropathy

  2016cited by this paper
• Plasma copeptin in children and adolescents with type 1 diabetes mellitus in comparison to healthy controls.

  2016cited by this paper
• Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials

  2016cited by this paper
• Metabolomics in diabetic complications.

  2016cited by this paper
• TGF-β: the master regulator of fibrosis

  2016cited by this paper
• Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.

  2016cited by this paper
• TGF-β1, in association with the increased expression of connective tissue growth factor, induce the hypertrophy of the ligamentum flavum through the p38 MAPK pathway

  2016cited by this paper
• MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy

  2016cited by this paper
• Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes

  2016cited by this paper
• Increased urinary angiotensinogen precedes the onset of albuminuria in normotensive type 2 diabetic patients.

  2015cited by this paper
• MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets

  2015cited by this paper
• Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy

  2015cited by this paper
• Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes

  2015cited by this paper
• Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction

  2015influential reference
• Lipocalin-type prostaglandin D2 synthase reduces glucagon secretion in alpha TC-1 clone 6 cells via the DP1 receptor

  2015cited by this paper
• Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

  2015influential reference
• Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A.

  2015cited by this paper
• The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes

  2015cited by this paper
• Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice

  2015influential reference
• Urinary biomarkers for early diabetic nephropathy: beyond albuminuria

  2015cited by this paper
• A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications

  2015cited by this paper
• Aldosterone up-regulates MMP-9 and MMP-9/NGAL expression in human neutrophils through p38, ERK1/2 and PI3K pathways.

  2015cited by this paper
• Aspectos celulares y moleculares de la nefropatía diabética, rol del VEGF-A

  2015cited by this paper
• Metabolomic biomarkers in diabetic kidney diseases--A systematic review.

  2015cited by this paper
• Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus.

  2015influential reference
• Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus

  2015cited by this paper
• Novel urinary biomarkers in pre-diabetic nephropathy

  2015cited by this paper
• Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes.

  2014cited by this paper
• Uremic solutes and risk of end stage renal disease in type 2 diabetes

  2014influential reference
• Bilirubin and Progression of Nephropathy in Type 2 Diabetes: A Post Hoc Analysis of RENAAL With Independent Replication in IDNT

  2014cited by this paper
• Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.

  2014influential reference
• Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status

  2014cited by this paper
• Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

  2014influential reference
• Urinary type IV collagen is related to left ventricular diastolic function and brain natriuretic peptide in hypertensive patients with prediabetes.

  2014cited by this paper
• Nephrin – a biomarker of early glomerular injury

  2014cited by this paper
• NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up

  2014cited by this paper
• Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus

  2013cited by this paper
• Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes

  2013cited by this paper
• MicroRNAs: potential mediators and biomarkers of diabetic complications.

  2013cited by this paper
• Urinary liver type fatty acid binding protein in diabetic nephropathy.

  2013cited by this paper
• Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

  2013cited by this paper
• Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy

  2013cited by this paper
• Diabetic nephropathy: diagnosis and treatment

  2013cited by this paper
• Aqp5 Is a New Transcriptional Target of Dot1a and a Regulator of Aqp2

  2013cited by this paper
• Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes

  2013cited by this paper
• Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray

  2013cited by this paper
• Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients

  2013cited by this paper
• Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy

  2013cited by this paper
• Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus.

  2013cited by this paper
• The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes

  2013cited by this paper
• Low-Grade Proteinuria and Microalbuminuria in Renal Transplantation

  2013cited by this paper
• The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus

  2013cited by this paper
• Urinary biomarkers of diabetic nephropathy

  2013cited by this paper
• Diabetic nephropathy: diagnosis, prevention and treatment

  2013cited by this paper
• Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study

  2012cited by this paper
• Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc

  2012cited by this paper
• Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

  2012cited by this paper
• Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C are Effective for Detection of Diabetic Nephropathy in Childhood Diabetic Patients

  2012cited by this paper
• Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin

  2012cited by this paper
• Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance

  2012cited by this paper
• Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes

  2012cited by this paper
• Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C

  2012cited by this paper
• Urinary Markers of Glomerular Injury in Diabetic Nephropathy

  2012cited by this paper
• Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria

  2012cited by this paper
• The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease

  2012cited by this paper
• Differential expression of laminin isoforms in diabetic nephropathy and other renal diseases

  2012cited by this paper
• Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

  2012cited by this paper
• Uric acid as a mediator of diabetic nephropathy.

  2011cited by this paper
• Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes.

  2011cited by this paper
• “Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL

  2011cited by this paper
• Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration

  2011cited by this paper
• Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes

  2011cited by this paper
• Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients

  2011cited by this paper
• A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

  2011cited by this paper
• Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

  2011cited by this paper
• Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

  2011cited by this paper
• Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy

  2011cited by this paper
• β-trace protein versus cystatin C: which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases?

  2011cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes.

  2011cited by this paper
• Biomarkers in chronic kidney disease: a review.

  2011cited by this paper
• Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.

  2011cited by this paper
• Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus

  2011cited by this paper
• Pentosidine and N-Carboxymethyl-Lysine: Biomarkers for Type 2 Diabetic Retinopathy

  2011cited by this paper
• Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.

  2010cited by this paper

• Identification of diabetic kidney disease biomarkers via iTRAQ plasma proteomics analysis.

  2026cites this paper
• NMR metabolomics in genetically engineered mouse models

  2025cites this paper
• DNA methylation biomarkers in diabetic kidney disease: insights and implications

  2025cites this paper
• Tubular Injury in Diabetic Kidney Disease: Early Diagnosis and Intervention Strategies

  2025cites this paper
• Endogenous Non-Invasive Early Biomarkers for Diabetic Nephropathy in Type 2 Diabetic Saudi Patients: A Case Control Study

  2025influential citation
• Polygonati Rhizoma Polysaccharides Ameliorated Diabetic Kidney Disease in db/db Mice via Inhibiting TGFβ /Smad2 Signaling Pathway

  2025cites this paper
• Factors contributing to transient and persistent worsening renal function in elderly patients with acute decompensated heart failure

  2025cites this paper
• Serum neutrophil gelatinase associated Lipocalin as a novel biomarker for diagnosing acute pyelonephritis in adults

  2025cites this paper
• Biomarkers in diabetic nephropathy: A comprehensive review of their role in early detection and disease progression monitoring.

  2025cites this paper
• Targeting inflammation and necroptosis in diabetic kidney disease: A novel approach via PPARα modulation.

  2025cites this paper
• PREVENTING DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW OF CURRENT PHARMACOLOGICAL APPROACHES

  2025cites this paper
• Danggui Buxue Decoction Regulates Autophagy to Improve Renal Fibrosis in diabetes through miR-27a /PI3K/AKT pathway.

  2025cites this paper
• Risk factor assessment of prediabetes and diabetes based on epidemic characteristics in new urban areas: a retrospective and a machine learning study

  2025cites this paper
• The Key Role of Nutritional Intervention in Delaying Disease Progression and the Therapeutic Management of Diabetic Kidney Disease—A Challenge for Physicians and Patients

  2024cites this paper
• Insights into the Novel Biomarkers Expressed in Diabetic Nephropathy: Potential Clinical Applications.

  2024cites this paper
• Deciphering the ameliorative effect of Aloe vera (L.) Burm. f. extract on histopathological alterations in Streptozotocin-induced WNIN/GR-Ob rats.

  2024cites this paper
• Wogonin Alleviates Streptozotocin-stimulated Diabetic Nephropathy through its Antidiabetic, Antidyslipidemic, and Antioxidative Effects in Rats

  2024cites this paper
• Novel Biomarkers for the diagnosis of diabetic nephropathy

  2024cites this paper
• Correlation of Urinary Gamma Glutamyl Transferase to Creatinine Ratio with Albumin Creatinine Ratio in Patients with Type 2 Diabetes Mellitus

  2024cites this paper
• An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies.

  2024cites this paper
• Urinary SIRT2 Reflects Kidney Injury in Type 2 Diabetes.

  2024cites this paper
• Analysis of clinical evidence on traditional Chinese medicine for the treatment of diabetic nephropathy: a comprehensive review with evidence mapping

  2024cites this paper
• Development of Serum Lactate Level-Based Nomograms for Predicting Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

  2024cites this paper
• A meta-analysis of urinary transferrin for early diagnosis of diabetic nephropathy.

  2024cites this paper
• Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy

  2024cites this paper
• Development of Web-based Novel Machine Learning Model Using Boosting Techniques for Early Prediction of Diabetes in Indian Adults

  2023cites this paper
• Transcriptomics-proteomics Integration reveals alternative polyadenylation driving inflammation-related protein translation in patients with diabetic nephropathy

  2023cites this paper
• Urinary orosomucoid and retinol binding protein levels as early diagnostic markers for diabetic kidney Disease

  2023cites this paper
• Traditional Chinese medicine for the treatment of immune-related nephropathy: A review

  2023cites this paper
• Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy

  2023cites this paper
• Stem cells as a regenerative medicine approach in treatment of microvascular diabetic complications.

  2023cites this paper
• Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy

  2023cites this paper
• Nutritional Composition and Anti-Type 2 Diabetes Mellitus Potential of Femur Bone Extracts from Bovine, Chicken, Sheep, and Goat: Phytochemical and In Vivo Studies

  2023cites this paper
• Correlation Analysis of Vascular Endothelial Growth Factor Level with Clinicopathological Features and Prognosis in Patients with Diabetic Nephropathy: A Biopsy-based Study.

  2023cites this paper
• Identifying Aging-Related Biomarkers and Immune Infiltration Features in Diabetic Nephropathy Using Integrative Bioinformatics Approaches and Machine-Learning Strategies

  2023cites this paper
• Cobalt oxide modified sulfur and phosphorus Co-doped g-C3N4 for screening of urinary human albumin

  2023cites this paper
• Lysozyme promotes renal fibrosis through the JAK/STAT3 signal pathway in diabetic nephropathy

  2023cites this paper
• The relationship between serum γ-glutamyltransferase (GGT) and diabetic nephropathy in patients with type 2 diabetes mellitus: a cross-sectional study

  2023cites this paper
• Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients

  2023cites this paper
• Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease

  2023cites this paper
• Low-dose lipopolysaccharide inducing continuous and obvious increase in urinary protein in hyperglycemic rats and the underlying mechanism

  2023cites this paper
• Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation.

  2023cites this paper
• Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease

  2023cites this paper
• Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

  2023cites this paper
• Expression of Angiopoetin-Like Protein-4 and Kidney Injury Molecule-1 as Preliminary Diagnostic Markers for Diabetes-Related Kidney Disease: A Single Center-Based Cross-Sectional Study

  2023cites this paper
• Urine Immunoglobin G Greater Than 2.45 mg/L Has a Correlation with the Onset and Progression of Diabetic Kidney Disease: A Retrospective Cohort Study

  2023cites this paper
• Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?

  2023cites this paper
• Progress in understanding primary glomerular disease: insights from urinary proteomics and in-depth analyses of potential biomarkers based on bioinformatics

  2023cites this paper
• Capability of intravoxel incoherent motion and diffusion tensor imaging to detect early kidney injury in type 2 diabetes

  2022cites this paper
• Screening, Early Diagnosis, Genetic Markers and Predictors of Progression

  2022cites this paper
• Association of significantly elevated plasma levels of NGAL and IGFBP4 in patients with diabetic nephropathy

  2022influential citation
• Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis

  2022cites this paper
• Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial

  2022cites this paper
• High Glycated Hemoglobin Instead of High Body Mass Index Might Increase the Urine N-Acetyl-β-D-glucosaminidase Con-Centration in Children and Adolescents with Diabetes Mellitus

  2022cites this paper
• The Leaves of Cyclocarya paliurus: A Functional Tea with Preventive and Therapeutic Potential of Type 2 Diabetes.

  2022cites this paper
• Ferulic acid ameliorates renal injury via improving autophagy to inhibit inflammation in diabetic nephropathy mice.

  2022cites this paper
• Cystatin C, renal resistance index, and kidney injury molecule-1 are potential early predictors of diabetic kidney disease in children with type 1 diabetes

  2022cites this paper
• The diagnostic model for early detection of gestational diabetes mellitus and gestational diabetic nephropathy

  2022cites this paper
• Exploring the pathogenesis of diabetic kidney disease by microarray data analysis

  2022cites this paper
• Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease

  2022cites this paper
• Association of amino acids related to urea cycle with risk of diabetic nephropathy in two independent cross-sectional studies of Chinese adults

  2022cites this paper
• UPLC-HDMSE to discover serum biomarkers in adults with type 1 diabetes.

  2022cites this paper
• Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases

  2022cites this paper
• Biomolecular Mechanisms of Cardiorenal Protection with Sodium-Glucose Co-Transporter 2 Inhibitors

  2022cites this paper
• Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches

  2022cites this paper
• Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus

  2022cites this paper
• Beneficial effects of ginsenosides on diabetic nephropathy: A systematical review and meta-analysis of preclinical evidence.

  2022cites this paper
• The ubiquitination of CKIP-1 mediated by Src aggravates diabetic renal fibrosis (original article).

  2022cites this paper
• Non-albuminuric Diabetic Kidney Disease Phenotype: Beyond Albuminuria

  2022influential citation
• Circular RNA expression profile in transgenic diabetic mouse kidneys

  2021cites this paper
• Value of Intrarenal Artery Resistive Index for Detecting Diabetic Kidney Disease: A Cross- sectional Study

  2021cites this paper
• DMSO_A_291314 355..366

  2021cites this paper
• Protective Effect of Adalimumab on Diabetic Nephropathy by Regulating TNF-α Signal Pathway

  2021cites this paper
• Utility of urinary progranulin in patients with type 2 diabetic nephropathy and its correlation with renal function

  2021cites this paper
• PPBP as a marker of diabetic nephropathy podocyte injury via Bioinformatics Analysis.

  2021cites this paper
• Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy

  2021cites this paper
• NGAL and IGFBP4 in patients with diabetic nephropathy

  2021cites this paper
• Effects of soy isoflavone supplementation on patients with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials.

  2021cites this paper
• MicroRNA expression profiling in diabetic kidney disease.

  2021cites this paper
• AI-based prediction model for the risk of diabetic kidney disease in patients with type 2 diabetes mellitus

  2021cites this paper
• The Kidney in Type I Diabetes

  2021cites this paper
• Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia

  2021influential citation
• Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus

  2021cites this paper
• Diabetic nephropathy: early markers for monitoring and prevention

  2021cites this paper
• Increased serum asprosin is correlated with diabetic nephropathy

  2021cites this paper
• Alteration of gut microbial profile in patients with diabetic nephropathy

  2021cites this paper
• Diabetic Nephropathy – a Review of Risk Factors, Progression, Mechanism, and Dietary Management

  2021cites this paper
• Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats

  2021cites this paper
• Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy

  2021cites this paper
• Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.

  2021cites this paper
• PARP-1 and SIRT-1 are Interacted in Diabetic Nephropathy by Activating AMPK/PGC-1α Signaling Pathway

  2021cites this paper
• Application of multiparametric MR imaging to predict the diversification of renal function in miR29a-mediated diabetic nephropathy

  2021cites this paper
• Knockdown of CTRP6 inhibits high glucose‐induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells through regulating the Akt/NF‐κB pathway

  2020cites this paper
• Liver Stiffness Is Associated With Progression of Albuminuria in Adults With Type 2 Diabetes: Nonalcoholic Fatty Disease Cohort Study.

  2020cites this paper
• Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103+ DCs‐mediated CD8+ T cell responses

  2020cites this paper
• Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study

  2020cites this paper
• Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort

  2020cites this paper
• Urinary interleukin-6 and tumour necrosis factor-alpha as early markers for diabetic nephropathy in children and adolescents with type 1 diabetes

  2020cites this paper
• DDDT_A_274256 4135..4148

  2020cites this paper
• Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy

  2020cites this paper